Table 5.
Variable | Treatment1 | SEM | P-value | |||
---|---|---|---|---|---|---|
CON | MCFA | Treatment | Time | Treatment ×Time | ||
Pre-calving | ||||||
IL3-2 (pg/mL) | 152.05 | 152.33 | 2.202 | 0.57 | 0.04 | 0.29 |
IL-6 (ng/mL) | 382.09 | 385.57 | 5.446 | 0.75 | 0.10 | 0.33 |
IL-8 (ng/mL) | 82.65 | 80.34 | 1.074 | 0.28 | 0.07 | 0.51 |
IL-10 (pg/mL) | 197.46 | 204.69 | 3.026 | 0.23 | 0.10 | 0.44 |
TNF-α3 (pg/L) | 228.75 | 217.82 | 3.318 | 0.12 | 0.28 | 0.80 |
MPO3 (U/L) | 125.48 | 126.08 | 1.253 | 0.83 | 0.78 | 0.82 |
SAA3 (μg/mL) | 32.54 | 31.62 | 0.649 | 0.47 | 0.11 | 0.21 |
Early lactation | ||||||
IL-2 (pg/mL) | 159.17 | 160.12 | 2.338 | 0.85 | 0.30 | 0.40 |
IL-6 (ng/mL) | 405.38 | 415.11 | 7.003 | 0.42 | <0.01 | 0.06 |
IL-8 (ng/mL) | 88.02 | 91.39 | 1.519 | 0.29 | 0.31 | 0.29 |
IL-10 (pg/mL) | 214.44 | 213.98 | 3.375 | 0.92 | <0.01 | 0.21 |
TNF-α (pg/L) | 234.38 | 234.14 | 2.655 | 0.97 | 0.33 | 0.78 |
MPO (U/L) | 140.22a | 133.81b | 1.526 | 0.04 | 0.28 | 0.13 |
SAA (μg/mL) | 32.24a | 29.92b | 0.561 | 0.03 | 0.01 | 0.29 |
Peak lactation | ||||||
IL-2 (pg/mL) | 135.11 | 138.74 | 3.171 | 0.59 | 0.38 | 0.43 |
IL-6 (ng/mL) | 416.84 | 436.53 | 9.149 | 0.32 | 0.56 | 0.69 |
IL-8 (ng/mL) | 97.96 | 96.51 | 1.614 | 0.68 | 0.66 | 0.42 |
IL-10 (pg/mL) | 231.24 | 230.32 | 3.373 | 0.89 | 0.06 | 0.82 |
TNF-α (pg/L) | 238.10 | 229.13 | 4.321 | 0.25 | 0.27 | 0.01 |
MPO (U/L) | 132.43 | 141.04 | 3.049 | 0.19 | 0.51 | 0.48 |
SAA (μg/mL) | 31.06 | 30.58 | 0.820 | 0.76 | 0.05 | 0.14 |
SEM, standard error of mean.
a-bMeans within a row with unlike superscripts differ (P ≤ 0.05).
1CON, control treatment, basic diet with no medium chain fatty acids, n = 9. MCFA = MCFA treatment, basic diet and medium chain fatty acids 20 g/d, n = 9.
2Pre-calving, from 21 d before calving to calving, Early lactation = from 1 d to 28 d after calving, Peak lactation= from 29 d to 70 d after calving.
3IL, interleukin, TNF- α, tumor necrosis factor α; MPO, myeloperoxidase; SAA, serum amyloid protein A.